EOD Primary Tumor

This input is used for staging

Default

999

NAACCR Item

NAACCR #772

Code	Description	SS2018 T
000	In situ, intraepithelial, noninvasive	IS
100	Tumor of any size - WITH or WITHOUT extraglandular extension into the orbital soft tissue - No periosteal or orbital bone involvement or UNKNOWN if involved Localized, NOS	L
200	Tumor of any size - Periosteal involvement only	RE
300	Tumor of any size - Periosteal and bone involvement	RE
700	Involvement of adjacent structures, including - Brain - Cavernous sinus - Orbital bone - Periosteum - Pterygoid fossa - Sinuses - Superior orbital fissure - Temporal fossa	D
800	No evidence of primary tumor	U
999	Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record Death Certificate Only	U

(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998 (2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001. (3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL) (4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30 (5) White, V.A., Finger, P.T., et al. **Lacrimal Gland Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 833-839